Tuna Ustunkaya1, Benoit Desjardins2, Riley Wedan1, C Anwar A Chahal1, Stefan L Zimmerman3, Nissi Saju4, Sohail Zahid5, Apurva Sharma4, Yuchi Han5, Natalia Trayanova6, Francis E Marchlinski1, Hugh Calkins4, Harikrishna Tandri4, Saman Nazarian7. 1. Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 3. Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Cardiac Electrophysiology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 6. Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland. 7. Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: saman.nazarian@uphs.upenn.edu.
Abstract
OBJECTIVES: This study sought to evaluate the association between contrast-enhanced multidetector computed tomography (CE-MDCT) attenuation and local epicardial conduction speed (ECS) and electrographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and ventricular tachycardia (VT). BACKGROUND: CE-MDCT is a widely available and fast imaging technology with high spatial resolution that is less prone to defibrillator generator-related safety issues and image artifacts. However, the association between hypoattenuation on MDCT and VT substrates in ARVC remains unknown. METHODS: Patients with ARVC who underwent CE-MDCT followed by endocardial (n = 30) and epicardial (n = 21) electroanatomical mapping (EAM) and VT ablation were prospectively enrolled. Right ventricular (RV) mid-myocardial attenuation was calculated from 3-dimensional MDCT images and registered to EAM. Local ECS was calculated by averaging the ECS between each point and 5 adjacent points with concordant wave front direction. RESULTS: A total of 17,311 epicardial and 5,204 endocardial points were included. In multivariable regression analysis clustered by patient, RV myocardial attenuation was associated with epicardial bipolar voltage amplitude (2.5% decrease in amplitude per 10 HU decrease in attenuation; p < 0.001), with endocardial unipolar voltage amplitude (0.9% decrease in amplitude per 10 HU decrease in attenuation; p < 0.001), and with ECS (0.4% decrease in ECS per 10 HU decrease in attenuation; p = 0.001). CONCLUSIONS: CE-MDCT attenuation distribution is associated with regional ECS and electrographic amplitude in ARVC. Regions with low attenuation likely reflect fibro-fatty involvement in the RV and may serve as important VT substrates in patients with ARVC who are undergoing VT ablation.
OBJECTIVES: This study sought to evaluate the association between contrast-enhanced multidetector computed tomography (CE-MDCT) attenuation and local epicardial conduction speed (ECS) and electrographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and ventricular tachycardia (VT). BACKGROUND: CE-MDCT is a widely available and fast imaging technology with high spatial resolution that is less prone to defibrillator generator-related safety issues and image artifacts. However, the association between hypoattenuation on MDCT and VT substrates in ARVC remains unknown. METHODS:Patients with ARVC who underwent CE-MDCT followed by endocardial (n = 30) and epicardial (n = 21) electroanatomical mapping (EAM) and VT ablation were prospectively enrolled. Right ventricular (RV) mid-myocardial attenuation was calculated from 3-dimensional MDCT images and registered to EAM. Local ECS was calculated by averaging the ECS between each point and 5 adjacent points with concordant wave front direction. RESULTS: A total of 17,311 epicardial and 5,204 endocardial points were included. In multivariable regression analysis clustered by patient, RV myocardial attenuation was associated with epicardial bipolar voltage amplitude (2.5% decrease in amplitude per 10 HU decrease in attenuation; p < 0.001), with endocardial unipolar voltage amplitude (0.9% decrease in amplitude per 10 HU decrease in attenuation; p < 0.001), and with ECS (0.4% decrease in ECS per 10 HU decrease in attenuation; p = 0.001). CONCLUSIONS: CE-MDCT attenuation distribution is associated with regional ECS and electrographic amplitude in ARVC. Regions with low attenuation likely reflect fibro-fatty involvement in the RV and may serve as important VT substrates in patients with ARVC who are undergoing VT ablation.
Authors: Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba Journal: Circulation Date: 2010-02-19 Impact factor: 29.690
Authors: Christian L Stanton; Linda B Haramati; Netanel S Berko; Mark I Travin; Vineet R Jain; Adam H Jacobi; William B Burton; Jeffrey M Levsky Journal: J Cardiovasc Comput Tomogr Date: 2010-11-26
Authors: Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Sohail Zahid; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David Spragg; Hiroshi Ashikaga; Natalia Trayanova; Gordon F Tomaselli; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian Journal: Circ Arrhythm Electrophysiol Date: 2016-03
Authors: Takeshi Sasaki; Hugh Calkins; Christopher F Miller; Menekhem M Zviman; Vadim Zipunnikov; Tomio Arai; Motoji Sawabe; Masashiro Terashima; Joseph E Marine; Ronald D Berger; Saman Nazarian; Stefan L Zimmerman Journal: Heart Rhythm Date: 2015-03-23 Impact factor: 6.343
Authors: Glenn M Polin; Haris Haqqani; Wendy Tzou; Mathew D Hutchinson; Fermin C Garcia; David J Callans; Erica S Zado; Francis E Marchlinski Journal: Heart Rhythm Date: 2010-11-27 Impact factor: 6.343
Authors: Peter M Kistler; Prashanthan Sanders; Simon P Fynn; Irene H Stevenson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094